Related Experiment Video
Updated: May 5, 2026

Fabrication of Small Caliber Stent-grafts Using Electrospinning and Balloon Expandable Bare Metal Stents
Published on: October 26, 2016
Development of a Drug-Loaded Shape-Memory Polymer Urethral Stent (SMPUS) for Treatment of Prostatic Urethral
Alaa Fehaid1,2,3, Koichiro Uto1, Toshimasa Homma1,2
1Research Center for Macromolecules and Biomaterials, National Institute for Materials Science (NIMS), 1-1 Namiki, Tsukuba, Ibaraki 305-0044, Japan.
Abstract:
Prostatic urethral obstruction (PUO) is the urethral narrowing by the external pressure of an enlarged prostate, which hinders the ability to pass urine normally. The most common reasons for an enlarged prostate are prostate cancer and benign prostate hyperplasia. In this study, we aimed to develop a drug-loaded shape-memory polymer urethral stent (SMPUS) to address PUO. The SMPUS was designed to combine both mechanical and chemical/herbal treatment of PUO. Successfully, SMPUS shows potential mechanical efficacy through its shape-memory properties that ensure the patency of the urethral lumen by restoring its tube-like stent shape upon flushing with hot water at its melting temperature. Additionally, the in vitro drug release investigation shows the capability of SMPUS to serve as a versatile drug delivery platform, after further in vivo investigation, enabling the release of the selected drugs to treat the primary diseases associated with PUO while mitigating the systemic side effects associated with conventional treatments. Both polymer and drug concentrations can be modulated to achieve the required mechanical and thermal properties based on the case progress. This adaptability of the developed SMPUS allows for future in vivo and clinical trials in medical applications.
More Related Videos
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Site-Targeted
Site-Targeted Drug Delivery Systems: Polymeric Carriers

